Haverford Financial Services, Inc. Gilead Sciences, Inc. Transaction History

Haverford Financial Services, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$57.92 - $72.58 $981,744 - $1.23 Million	-16,950 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $6,033 - $6,848	-93 Reduced 0.55%	16,950 $1.23 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $812 - $876	-12 Reduced 0.07%	17,043 $1.19 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $1.08 Million - $1.18 Million	17,055 New	17,055 $1.17 Million

1,879

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Haverford Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Haverford Financial Services, Inc. with notifications on news.